Avidity Biosciences, Inc. (RNA)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Sarah Boyce |
| Employees: | 190 |
| Web site: | aviditybiosciences.com |
|
10578 SCIENCE CENTER DRIVE, SUITE 125, SAN DIEGO, CA, 92121
858-401-7900
| |
Are you looking for these stocks instead?
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Avidity Biosciences, Inc. engages in the development of oligonucleotide-based therapies. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the. treatment of Duchenne Muscular Dystrophy.
Please log in first to see chart